Terug
58
Ook genoteerd als
KCDMF
OTC
Dagbereik
€ 11,12
€ 11,45
52-Weeksbereik
€ 7,55
€ 12,69
Volume
11.835
50D / 200D Gem.
€ 11,73
/
€ 10,30
Vorige Slotkoers
€ 10,97
Koershistorie
Financiële Trends
Sectorvergelijking
vs Consumer Defensive sector mediaan (329 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 1,0 | 10,4 |
| P/B | 0,9 | 1,2 |
| ROE % | 97,0 | 12,6 |
| Net Margin % | 13,7 | 5,3 |
| Rev Growth 5Y % | 2,6 | 5,5 |
| D/E | 3,1 | 0,6 |
Belangrijkste Punten
Revenue grew 2,59% annually over 5 years — modest growth
ROE of 97,04% indicates high profitability
Debt/Equity of 3,05 — high leverage
Generating 6,09B in free cash flow
P/E of 0,96 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 7,79%
Groei
Revenue Growth (5Y)
2,59%
Revenue (1Y)-5,20%
Earnings (1Y)-9,19%
FCF Growth (3Y)-25,89%
Kwaliteit
Return on Equity
97,04%
ROIC28,92%
Net Margin13,69%
Op. Margin21,80%
Veiligheid
Debt / Equity
3,05
Current Ratio1,45
Interest Coverage5,73
Waardering
P/E Ratio
0,96
P/B Ratio0,94
EV/EBITDA1,70
Dividend Yield0,05%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -5,20% | Revenue Growth (3Y) | -1,30% |
| Earnings Growth (1Y) | -9,19% | Earnings Growth (3Y) | 0,70% |
| Revenue Growth (5Y) | 2,59% | Earnings Growth (5Y) | 12,16% |
| Profitability | |||
| Revenue (TTM) | 51,94B | Net Income (TTM) | 7,11B |
| ROE | 97,04% | ROA | 15,56% |
| Gross Margin | 38,88% | Operating Margin | 21,80% |
| Net Margin | 13,69% | Free Cash Flow (TTM) | 6,09B |
| ROIC | 28,92% | FCF Growth (3Y) | -25,89% |
| Safety | |||
| Debt / Equity | 3,05 | Current Ratio | 1,45 |
| Interest Coverage | 5,73 | Dividend Yield | 0,05% |
| Valuation | |||
| P/E Ratio | 0,96 | P/B Ratio | 0,94 |
| P/S Ratio | 0,13 | PEG Ratio | -2,44 |
| EV/EBITDA | 1,70 | Dividend Yield | 0,05% |
| Market Cap | 6,81B | Enterprise Value | 19,24B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 51,94B | 54,78B | 53,31B | 51,06B | 46,89B |
| Net Income | 7,11B | 7,83B | 7,01B | 4,94B | 4,49B |
| EPS (Diluted) | 11,90 | 12,75 | 11,40 | 8,05 | 7,30 |
| Gross Profit | 20,19B | 22,38B | 20,70B | 16,77B | 15,79B |
| Operating Income | 11,32B | 12,85B | 11,93B | 8,94B | 8,35B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 45,71B | 52,11B | 53,92B | 53,54B | 48,78B |
| Total Liabilities | 38,46B | 44,70B | 47,00B | 48,51B | 43,06B |
| Shareholders' Equity | 7,25B | 7,41B | 6,92B | 5,03B | 5,72B |
| Total Debt | 22,11B | 28,10B | 29,72B | 34,15B | 29,83B |
| Cash & Equivalents | 9,68B | 15,58B | 16,86B | 16,92B | 12,27B |
| Current Assets | 22,68B | 29,30B | 31,21B | 28,61B | 23,54B |
| Current Liabilities | 15,60B | 20,49B | 18,73B | 14,67B | 15,25B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#91 of 658
Recente Activiteit
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026